ArticlePloS one2014
A descriptive model of patient readiness, motivators, and hepatitis C treatment uptake among Australian prisoners.
Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 57 citations in OpenAlex.
- A Qualitative Systematic Review of Barriers and Facilitators to Hepatitis B and C Programmes in Prisons.Journal of viral hepatitis · 2025Pooled it
- The impacts of and outcomes from telehealth delivered in prisons: A systematic review.PloS one · 2021Pooled it
- Care2Cure: A randomized controlled trial protocol for evaluating nurse case management to improve the hepatitis C care continuum within HIV primary care.Research in nursing & health · 2018Trial
- Incidence and correlates of hepatitis C virus infection in a large cohort of prisoners who have injected drugs.BMC public health · 2014Trial
- Article
- Hepatitis C virus micro-elimination in people who inject drugs: Challenges and chance in Taiwan and worldwide.The Kaohsiung journal of medical sciences · 2024Review
- Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework.Addiction (Abingdon, England) · 2023Article
- Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison.World journal of gastroenterology · 2022Article
- Article
- Article
- Opioid epidemic and liver disease.JHEP reports : innovation in hepatology · 2019Review
- Hepatitis C virus infection in Irish drug users and prisoners - a scoping review.BMC infectious diseases · 2019Article
- Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.Harm reduction journal · 2019Observational
- Hepatitis C virus screening and treatment in Irish prisons from nurse managers' perspectives - a qualitative exploration.BMC nursing · 2019Article
- Competing priorities and second chances - A qualitative exploration of prisoners' journeys through the Hepatitis C continuum of care.PloS one · 2019Article
- Hepatitis C virus screening and treatment in Irish prisons from a governor and prison officer perspective - a qualitative exploration.Health & justice · 2018Article
- Barriers and facilitators to hepatitis C (HCV) screening and treatment-a description of prisoners' perspective.Harm reduction journal · 2018Article
- Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era.Journal of the International AIDS Society · 2018Article
- 'Sussing that doctor out.' Experiences and perspectives of people affected by hepatitis C regarding engagement with private general practitioners in South Australia: a qualitative study.BMC family practice · 2017Article
- Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment.World journal of hepatology · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 5 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatitis C virus infection (HCV) has a significant global health burden with an estimated 2%-3% of the world's population infected, and more than 350,000 dying annually from HCV-related conditions including liver failure and liver cancer. Prisons potentially offer a relatively stable environment in which to commence treatment as they usually provide good access to health care providers, and are organised around routine and structure. Uptake of treatment of HCV, however, remains low in the community and in prisons. In this study, we explored factors affecting treatment uptake inside prisons and hypothesised that prisoners have unique issues influencing HCV treatment uptake as a consequence of their incarceration which are not experienced in other populations. METHOD AND
findingsWe undertook a qualitative study exploring prisoners' accounts of why they refused, deferred, delayed or discontinued HCV treatment in prison. Between 2010 and 2013, 116 Australian inmates were interviewed from prisons in New South Wales, Queensland, and Western Australia. Prisoners experienced many factors similar to those which influence treatment uptake of those living with HCV infection in the community. Incarceration, however, provides different circumstances of how these factors are experienced which need to be better understood if the number of prisoners receiving treatment is to be increased. We developed a descriptive model of patient readiness and motivators for HCV treatment inside prisons and discussed how we can improve treatment uptake among prisoners.
conclusionThis study identified a broad and unique range of challenges to treatment of HCV in prison. Some of these are likely to be diminished by improving treatment options and improved models of health care delivery. Other barriers relate to inmate understanding of their illness and stigmatisation by other inmates and custodial staff and generally appear less amenable to change although there is potential for peer-based education to address lack of knowledge and stigma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.